Codexis and Nitto Denko Avecia Partner to Evaluate ECO Synthesis® Platform for Next-Generation Oligonucleotide Manufacturing

Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, and Nitto Denko Avecia, In...

October 31, 2025 | Friday | News
N2OFF Completes Merger with MitoCareX Bio to Expand into Cancer Drug Discovery Targeting Mitochondrial Proteins

N2OFF, Inc. a cleantech company investing in solar energy assets based on the RTB (Ready to Build) business model, recently announced the closing of the ...

October 31, 2025 | Friday | News
Thermo Fisher Scientific to Acquire Clario for $8.9 Billion to Accelerate Digital Transformation of Clinical Research

Expected to be immediately accretive to Adjusted Earnings Per Share (EPS)¹ after close Attractive return profile given high growth and strong margi...

October 30, 2025 | Thursday | News
Lonza Accelerates the Future of Pharma QC with Acquisition of Redberry and Its Breakthrough Red One™ Rapid Microbiology Platform

  Lonza to acquire Redberry SAS, an innovative company specializing in rapid microbiology testing solutions Acquisition to include Red One&trade...

October 29, 2025 | Wednesday | News
Fibronostics Acquires Stone Clinical Laboratories to Expand U.S. Operations and Advance Non-Invasive Diagnostics for Metabolic and Liver Diseases

Acquisition expands U.S. lab operations and accelerates innovation in non-invasive diagnostics for metabolic and liver diseases. Fibronostics, a global ...

October 28, 2025 | Tuesday | News
Vas Narasimhan Calls USD 12 Billion Avidity Acquisition a Defining Move to Advance Novartis Mission in Neuromuscular Disease Treatment

Transaction strengthens neuroscience franchise for Novartis with three late-stage programs that address genetic neuromuscular diseases Advances the No...

October 27, 2025 | Monday | News
Ipsen to Acquire ImCheck Therapeutics to Advance Promising AML Immunotherapy ICT01

Acquisition focused on lead clinical-stage program ICT01 in acute myeloid leukemia, where data from the ongoing Phase I/II EVICTION trial showed high t...

October 23, 2025 | Thursday | News
MilliporeSigma to Acquire JSR Life Sciences’ Chromatography Business to Strengthen Biologics Purification Capabilities

Acquisition aims to strengthen company’s downstream process offering of advanced filtration and chromatography solutions JSR’s innovativ...

October 16, 2025 | Thursday | News
EarlyHealth Group Acquires 50% Stake in CYB3R to Boost Global Cybersecurity for Life Sciences

EarlyHealth Group, a global pharmaceutical services and life sciences solutions company, has acquired a 50 % equity stake in CYB3R Limited, one of the Gu...

October 13, 2025 | Monday | News
Shuttle Pharmaceuticals to Acquire Molecule.ai for $10 Million to Accelerate AI-Driven Drug Discovery

Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a discovery and development stage spec...

October 13, 2025 | Monday | News
Lupin’s €190 Million Vision: Thierry Volle on Building a Global Ophthalmology Powerhouse

The €190 million acquisition of VISUfarma marks a pivotal moment in Lupin’s transformation into a global specialty-led biopharma. With VISUfarma...

October 08, 2025 | Wednesday | Interaction
MannKind Completes Acquisition of scPharmaceuticals to Strengthen Cardiometabolic Portfolio and Accelerate Growth

MannKind Corporation (Nasdaq: MNKD) successfully completed the previously announced acquisition of scPharmaceuticals Inc. The acquisition of scPhar...

October 08, 2025 | Wednesday | News
OXB Expands Global CDMO Footprint with Acquisition of Resilience’s FDA-Approved Viral Vector Manufacturing Facility in North Carolina

OXB acquires Resilience’s site in North Carolina, an FDA-approved, commercial-scale viral vector manufacturing facility In line with OXB’...

October 08, 2025 | Wednesday | News
Esperion Secures Key Patent Settlement with Dr. Reddy’s, Protecting NEXLETOL and NEXLIZET Until 2040

Esperion announced that it has entered into a settlement agreement with Dr. Reddy’s Laboratories, Inc. and its affiliate Dr. Reddy’s Laborato...

October 06, 2025 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close